Analysts' ratings for Novo Nordisk (NYSE:NVO) over the last quarter vary from bullish to bearish, as provided by 8 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 7 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 3 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 3 | 0 | 0 | 0 |
Analysts have recently evaluated Novo Nordisk and provided 12-month price targets. The average target is $160.75, accompanied by a high estimate of $163.00 and a low estimate of $160.00. This upward trend is apparent, with the current average reflecting a 3.93% increase from the previous average price target of $154.67.
Interpreting Analyst Ratings: A Closer Look
The analysis of recent analyst actions sheds...
Login or create a forever free account to read this news
Sign up/Log in